Utstrekt bruk av sovemedisin i Noreg

(03.02.2010) Forskarar ved Universitetet i Bergen/Nasjonalt Kompetansesenter for Søvnsykdommer har undersøkt bruk av sovemedisin og karakteristiske trekk ved sovemedisinbrukarar i Noreg. 19 % av dei spurte hadde brukt sovemedisin ein gong i livet, 8 % den siste månaden og 4 % brukte sovemedisin kronisk. Slik bruk var assosiert med låg sosioøkonomisk status, høgare alder og hyppige symptom på søvnproblem, angst og depresjon. Høg alder og lite kontroll over søvnen var dei tydelegaste faktorane for bruk og vanskar med å avslutte bruk. Heile 80% av dei som hadde brukt sovemedisin i løpet av livet ville foretrukke eit ikkje-medikamentelt behandlingsalternativ.

Dette syner at sovemedisinbruk er utbreidd i Noreg og at opplevinga av kontroll over eigen søvn spelar ei viktig rolle i medikamentbruken. Ikkje-medikamentell behandling er berre i liten grad del av helsetilbodet.

Int Clin Psychopharmacol. 2010 Jan 12.

Patient characteristics and predictors of sleep medication use.
Omvik S, Pallesen S, Bjorvatn B, Sivertsen B, Havik OE, Nordhus IH.

siri.omvik@gmail.com

Departments of aClinical Psychology bPsychosocial Science cPublic Health and Primary Health Care, University of Bergen dNorwegian Competence Center for Sleep Disorders, Haukeland University Hospital, Bergen, Norway.

The objective of this study was to investigate the characteristics of sleep medication users, and their satisfaction with treatment and subjective difficulty with quitting the drugs. A representative sample of 5000 adults in Norway was selected to participate in an epidemiologic study. The data were collected through a postal survey in which a total of 2645 (52.9%) participants responded. Weighted logistic regression was used to explore predictors for the drug pattern use. The prevalence of lifetime, current, and chronic use of sleep medications were 18.8, 7.9, and 4.2%. The use was associated with low socioeconomic status, older age, female sex, and frequent symptoms of sleep disorders, anxiety, and depression. Older age and low perceived control over sleep were the strongest predictors for use and difficulty in quitting sleep medications. Among responders who had ever used sleep medications, 80.3% would prefer a nonpharmacological treatment alternative. It is concluded that consumption of sleep medications is widespread in Norway, and that perception of control over sleep may play a significant role in the drug pattern use. Nonpharmacological treatment is to a small extent implemented in the health care sector.

PMID: 20071997

 Utskriftsvennlig side

Sist oppdatert: 03.02.2010 av Eldbjørg Fiske